SYNAGEVA BIOPHARMA CORP 4
4 · SYNAGEVA BIOPHARMA CORP · Filed Jun 10, 2013
Insider Transaction Report
Form 4
Glynn Michael
SVP Global Business Operations
Transactions
- Award
Stock Option (Right to Buy)
2013-06-06+40,000→ 40,000 totalExercise: $40.32Exp: 2023-06-06→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of the total number of shares subject to the option vest and become exercisable on June 6, 2014 and 1/36 of the remainder of the shares subject to the option shall vest and become exercisable monthly thereafter.